Aurora Cannabis (ACB) EBIT (2017 - 2026)

Aurora Cannabis (ACB) has reported EBIT for 10 consecutive years, with $3.0 million the latest figure, recorded in Q1 2026.

• Quarterly EBIT rose 117.78% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.8 million (up 161.89% YoY) and the FY2026 annual result came in at -$33.8 million, down 1048.62% from the prior year.
• EBIT eased to $3.0 million in Q1 2026 per ACB's latest filing, from $14.0 million in the prior quarter.
• Over the last five years, EBIT for ACB reached as high as $26.4 million in Q4 2024 and fell as low as -$4.8 billion in Q2 2023.
• A 5-year average of -$317.1 million and a median of -$4.9 million in 2023 frame the typical range for EBIT.
• Annual changes were most pronounced in 2023 — EBIT sank 10000.51% — and 2024, when it surged 304.13%.
• Year by year, EBIT stood at -$129.2 million in 2022, then soared by 90.0% to -$12.9 million in 2023, then jumped by 304.13% to $26.4 million in 2024, then tumbled by 46.83% to $14.0 million in 2025, then plunged by 78.77% to $3.0 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered $3.0 million, $14.0 million, and $2.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.